Embed Size (px)
Citation preview
Hyatt Regency Hotel, BirminghamFriday 20th October 2017
Platinum Sponsor
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Hyatt Regency Hotel, BirminghamFriday 20th October 2017
Lower Limb Endovascular Symposium 2017 4 5 Hyatt Regency Hotel, Birmingham
0830-0920 Registration
0920-0930 Welcome
0930-1040 Setting Up A Lower Limb Practice & Challenges in Imaging Chairs – David Shaw & Simon Neequaye
0930-0945 How I set up a Lower Limb Practice – Considerations & Pitfalls
Leith Williams, Wirral
0945-1000 Setting up a Daycase Peripheral Intervention Service Ray Ashleigh, Manchester
1000-1015 Challenges in Planning Interventions and assessing perfusion (Duplex, CTA and MRA)
Alex Horsch, Bristol
1015-1030 Getting the most from C02 Angiography Ulf Teichgraeber, Jena, Germany
1030-1040 Panel Discussion
1040-1140 Iliac Disease Chairs – Pete Holt & Leith Williams
1040-1105 How I approach Aorto-Iliac CTOs Klaus Overbeck, Sunderland
1105-1130 Difficult Iliac Cases & Bailout Strategies Martin Claridge, Birmingham
1130-1140 Panel Discussion
1140-1200 Coffee
1200-1315 Femoro-popliteal Disease (I) Chairs – Kaji Sritharan & Klaus Overbeck
1200-1215 Strategies to deal with calcification in the SFA Chris Twine, Newport
1215-1230 Endovascular Treatment of Common Femoral Artery Lesions – Where’s the Evidence?
Thomas Zeller, Germany
1230-1245 Subintimal versus Intraluminal for SFA lesions – which is best?
Alok Tiwari, Birmingham
1245-1305 POBA vs DCB vs Stenting for Femoropopliteal Disease – Current Evidence
Ulf Teichgraeber, Jena, Germany
1305-1315 Panel Discussion
1315-1410 Lunch
1410-1615 Femoro-popliteal Disease (II) Chairs – Thomas Zeller & Rob Hinchliffe
1410-1425 Management of In-Stent Re-stenosis
1425-1440 Tackling Bypass Graft stenosis – endovascular or surgery? Rob Davies, Leicester
1440-1510 DEBATE: Popliteal aneurysms: stenting is best FOR: Pete Holt, London AGAINST: Patrick Coughlin, Cambridge
1510-1525 Cook Medical: ‘The Elution Revolution’ – My strategy with X Zilver PTX
Jonathan Hopkins, Birmingham
1525-1550 Difficult Cases & Bailout Strategies Jonathan Smout, Liverpool
1550-1605 BASIL-3 Update Lewis Meecham, University of Birmingham
1605-1615 Panel Discussion
Programme
Lower Limb Endovascular Symposium 2017 6 7 Hyatt Regency Hotel, Birmingham
1615-1630 Coffee
1630-1815 BTK Disease Chairs –Alok Tiwari & Martin Claridge
1630-1650 My approach to BTK lesions David Shaw, Leeds
1650-1705 Angiosomes versus In-line flow – which is the best strategy?
Rob Hinchliffe, Bristol
1705-1725 Is there a role for DCB and DCS in BTK lesions? Kaji Sritharan, London
1725-1750 Difficult Cases & Bailout Strategies, incl. Safari technique Thomas Zeller, Germany
1750-1805 Role of Hybrid Techniques in the Lower Limb Mike Delbridge, Norfolk & Norwich
1805-1815 Panel Discussion
1815-1820 Closing Remarks
Platinum Sponsor
Cook MedicalSince 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.
Gold Sponsors
MedtronicDuring the six decades of Medtronic’s existence, our Mission has remained the same: to alleviate pain, restore health and extend life for people around the world. We have worked hard to be at the forefront of medical device innovation, challenging ourselves to develop high-quality therapies that positively impact people’s lives. We have accomplished a lot – today more than 62 million people benefit from our technologies each year, equating to two people every second. But the nature of today’s healthcare problems requires a new approach. Governments, insurers, hospitals, patients, and other participants in the healthcare system are looking for better value. At Medtronic, we believe that our technologies, the data and insights they create, and our expertise can be combined in partnership with hospitals, payers and governments to help create aligned, value-based healthcare models that can deliver better patient outcomes – while maintaining or reducing costs. At Medtronic, we are committed to accelerating the development of meaningful innovations for patients – innovations that add real value in better patient outcomes at appropriate costs, lead to enhanced quality of life, and can be validated by clinical and economic evidence. This year alone we have invested US$1.5 billion in research and development to bring meaningful innovations to market. And we’re not just thinking about this at the product level, we’re developing innovations for the therapy, procedure and system levels.Join us as we go Further, Together.
SpectraneticsSpectranetics’ peripheral Vascular Intervention products include Stellarex drug-coated balloon and AngioSculpt® scoring balloon as well as a range of laser catheters for ablation of blockages in arteries above and below the knee. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices.
Sponsors
Lower Limb Endovascular Symposium 2017 8 9 Hyatt Regency Hotel, Birmingham
The Company’s Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee, the AngioSculpt scoring balloon used in both peripheral and coronary procedures, and the Stellarex drug-coated balloon peripheral angioplasty platform, which received European CE mark approval in December 2014. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages inthe heart.
W. L. Gore & Associates (UK) LtdAt Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For several years now, we have also been voted one of the best workplaces in Europe and have been ranked on top workplace lists in France, Germany, Great Britain, Italy and Sweden. For more information, visit goremedical.com/eu.
Silver Sponsors
Bard Peripheral VascularBard Peripheral Vascular, Inc. has a tradition of vascular innovation with a focus on improving the quality of patients’ lives. It provides a range of interventional and surgical medical devices for the treatment of peripheral vascular, venous, dialysis access, biliary and tracheobroncheal disease. Featured Interventional products include the Lutonix® Paclitaxel Coated PTA Balloon Catheter (SFA, BTK & AV indications), the LifeStent® Vascular Stent Systems – available in lengths up to 250mm, Lifestream™ Balloon Expandable Vascular Covered Stentgraft, VascuTrak™ PTA Dilatation Catheter, Ultraverse® 014, 018 and 035 PTA Dilatation Catheters, Venovo Stent System and a range of unique tools for crossing chronic total occlusions with the Crosser® CTO Recanalization Catheter and Seeker® Crossing Support Catheter.Please visit our Bard representatives at the stand today, or contact us via our website: www.bardpv.com. Please consult product labels and package inserts for indications, contraindications, hazards, warnings and instructions for use.Brand Lutonix®, Seeker®, ReeKross™ Ultraverse®, Ultraverse® RX are tradesmarks and / or trademarks of C.R Bard Inc. Or an affiliate.
Boston ScientificBoston Scientific is dedicated to transforming the lives of patients by advancing the diagnosis and treatment of peripheral vascular disease and liver cancer with innovative technologies. We are a global leader in peripheral interventions and offer healthcare providers one of the broadest portfolio of solutions including a complete set of flow restoration technologies to treat the lower extremities. These include our crossing devices, a broad portfolio of balloons, stents and wires, atherectomy systems and thrombectomy devices, all designed to help physicians save the lives and limbs of more patients. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com
Cardinal HealthMore than passionate, more than partners, Cardinal Health is a pathway to better business. To greater care. To quicker cures. And to healthier outcomes for all.For decades, Cardinal Health has been honoured to serve hospitals, physicians, nurses, patients, pharmacists, manufacturers and others across the healthcare continuum. With the acquisition of Cordis, the company’s reach is now worldwide – and even more responsive to the needs of the global healthcare system. Cardinal Health enables Cordis to better serve an aging population and meet increasing demands for less-invasive medical treatments and more advanced medical products. Ultimately, Cordis is now even better positioned as part of Cardinal Health to serve customers.Together, Cordis and Cardinal Health create an unmatched offering in the cardiovascular and broader medical device space. Already a leader in interventional vascular technology, Cordis has combined with Cardinal Health to now offer high quality, daily-use products; reliable, trackable inventory and logistics; and deep analytic capabilities for a more comprehensive offering
PenumbraHeadquartered in Alameda, California, Penumbra, Inc. is a global healthcare company focused on interventional therapies. We design, develop, manufacture and market innovative devices. We have a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.”
Vascular Perspectives Ltd Vascular Perspectives Ltd is a medical device sales organisation with a passion for education and product support. We specialise in promoting unique and innovative products for use in interventional radiology and cardiology. Our representatives work throughout the United Kingdom and provide product and educational support
Lower Limb Endovascular Symposium 2017 10
LIMB PRESERVATIONSOLUTIONS
Your essential 4 Fr toolsbelow the knee
Compatible 4 Fr products
4 FR
SYSTEM
© COOK 09/2017 PI-D37583-EN-F
.014"
.014" compatible
4 Fr
170 cm shaft
Flexor® Technology
Guiding Sheaths
Approach® Hydro STMicrowire Guide
Advance®
PTA Balloon Dilatation Catheters
4 Fr | 2.6 Fr | 2.3 Fr coaxial system
CXI®
Support Catheter
Download our infrapopliteal procedure guide.cookmedical.eu/cli
cookmedical.eu/cli
for clinical teams. We believe education is motivation and is a critical component that allows clinicians to make the correct equipment choice to maximise procedural success. Working with key opinion leaders to communicate new ideas and techniques, we design highly informative educational programmes to support both our products, and associated procedures.
Bronze Sponsors
Abbott VascularAbbott Vascular, a division of Abbott, is a global leader in vascular and cardiac care with market-leading products and an industry-leading pipeline. Headquartered in Northern California, we are committed to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education. We offer cutting-edge devices for coronary artery disease, peripheral vascular disease, carotid artery disease and structural heart disease. Our comprehensive product portfolio includes the Xience PRIME drug eluting stent system, self-expanding and balloon expanding bare metal stents, balloon catheters, guide wires and vessel closure devices
Terumo Interventional SystemsAt Terumo Interventional Systems, we constantly work to refine and perfect our products so that interventionalists can do more. That is why we support great thinking that pushes back the boundaries of our field. We are committed to innovation that embraces intricacies and complexities. Our exceptional tools and education programs empower physicians with the confidence they need to perform ever-more challenging procedures and spark progress. We look forward to seeing you at the Terumo booth at the Lower Limb Symposium.
GE Healthcare GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to morepeople around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.
email: [email protected]
